Climedo Connect
Patient Centricity and RWE – How Each Amplifies and Promotes the Other

October 17, 2024 | 3:00 – 4:00 PM CET 

RWE and Patient Centricity

Thursday, October 17, 2024 | 3:00 – 4:00 PM CET (Central European Time)

Explore the growing importance of combining patient-centric research with real-world data to transform healthcare delivery and improve patient outcomes in our Climedo Connect webinar "Patient Centricity and Real-World Evidence (RWE)". 

While RWE tells us "what" is happening with diseases, treatments and outcomes, Patient Centricity explains both "which" changes occur and "why". By incorporating patient-reported data on unmet needs, treatment experiences and wearables, we can enhance healthcare services and improve patient wellbeing.

Be part of our upcoming webinar on October 17, 2024 with Ella Balasa (advocate for patient engagement) and Dr. Chris Pashos (thought leader in the intersection of RWE and patient-centric healthcare) where they will share their expertise and explore practical strategies for leveraging RWE and patient-centric data to drive more meaningful improvements in patient care.

What to expect:

  • Learn why RWE and patient centricity are increasingly being recognized as critical to efforts to improve healthcare delivery and financing, and resulting patient outcomes.
  • Discover how RWE and patient centricity complement each other when it comes to the “what" and "why" in diseases, treatments and outcomes.
  • Find out how patient-reported data (including data from wearables) and overall experiences can enrich what is known and inform efforts to improve patient care and wellbeing. 

Don't miss this opportunity to deepen your understanding of the relationship between RWE and patient centricity. Register for free today!

Meet Our Speakers

CH
Catherine Higginson 

Associate Director, Marketing & Communications | Climedo

As Climedo's Marketing & Communications Manager and a EUPATI patient fellow, Catherine oversees the areas of industry research, content creation and collaboration with thought leaders and partners for marketing-related projects and events. She is passionate about showcasing the power of hybrid trials and RWE in the pharma and medtech industries.


 

 

Ella-Balasa
Ella Balasa

Patient Advocacy and Engagement Consultant

Ella Balasa is a patient advocate, consultant and person with cystic fibrosis. She empowers patients and advances healthcare strategies by speaking publicly on patient perspectives and distilling clinical information. Working with healthcare organizations clinical trial development and sharing patient experiences, she raises awareness of rare diseases and promotes self-advocacy. Learn more at www.ellabalasa.com.

 

 

 

Chris-Pashos
Dr. Chris Pashos

Member, Board of Directors
Genesis Research

Chris is dedicated to improving patient care and outcomes. He has demonstrated leadership in academia, consulting and global life sciences companies, primarily using RWE, patient-centric research and other aspects of HEOR to support the development and commercialization of innovative therapies. Currently he serves on the Board of Directors of Genesis Research to support life sciences companies.

 

 

 

What's on the Agenda?

  • Intro (Catherine Higginson)

  • Patient Centricity and RWE – How Each Amplifies and Promotes the Other (Ella Balasa, Dr. Chris Pashos)

  • Discussion and networking (all)

  • Wrap-up (Catherine Higginson)

Your Takeaways

INSIGHTS

Gain valuable insights into the relationship between RWE and patient centricity.

BEST PRACTICES

Discover how technology can be used to efficiently capture real-time data.

NETWORKING & DISCUSSION

Talk to other industry professionals and find out how they are tackling challenges similar to yours.

CLIMEDO

The leading European eCOA system for non-interventional studies, RWE and launch success

Climedo offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. By using a patient-centric approach and leveraging real-time data insights and visualizations around a study’s current progress, Climedo empowers its clients to better engage with healthcare professionals and other key opinion leaders (KOLs). This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster.

Founded in Munich in 2017, Climedo is a leading trusted partner for pharma, MedTech, CROs and academia with over 1.7 million patients enrolled to date. Learn more at www.climedo.com.

Climedo logo
Ecosystem2023